TY - JOUR AU - Jennette, J. C. AU - Falk, R. J. AU - Bacon, P. A. PY - 2013 DA - 2013// TI - 2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides JO - Arthritis Rheum VL - 65 UR - https://doi.org/10.1002/art.37715 DO - 10.1002/art.37715 ID - Jennette2013 ER - TY - JOUR AU - Harper, L. AU - Morgan, M. D. AU - Walsh, M. PY - 2012 DA - 2012// TI - Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up JO - Ann Rheum Dis VL - 71 UR - https://doi.org/10.1136/annrheumdis-2011-200477 DO - 10.1136/annrheumdis-2011-200477 ID - Harper2012 ER - TY - JOUR AU - De Groot, K. AU - Rasmussen, N. AU - Bacon, P. A. PY - 2005 DA - 2005// TI - Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis JO - Arthritis Rheum VL - 52 UR - https://doi.org/10.1002/art.21142 DO - 10.1002/art.21142 ID - De Groot2005 ER - TY - JOUR AU - Faurschou, M. AU - Westman, K. AU - Rasmussen, N. PY - 2012 DA - 2012// TI - Brief report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis JO - Arthritis Rheum VL - 64 UR - https://doi.org/10.1002/art.34547 DO - 10.1002/art.34547 ID - Faurschou2012 ER - TY - JOUR AU - Yates, M. AU - Watts, R. A. AU - Bajema, I. M. PY - 2016 DA - 2016// TI - EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis JO - Ann Rheum Dis VL - 75 UR - https://doi.org/10.1136/annrheumdis-2016-209133 DO - 10.1136/annrheumdis-2016-209133 ID - Yates2016 ER - TY - JOUR AU - Pagnoux, C. AU - Mahr, A. AU - Hamidou, M. A. PY - 2008 DA - 2008// TI - Azathioprine or methotrexate maintenance for ANCA-associated vasculitis JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0802311 DO - 10.1056/NEJMoa0802311 ID - Pagnoux2008 ER - TY - JOUR AU - Stone, J. H. AU - Merkel, P. A. AU - Spiera, R. PY - 2010 DA - 2010// TI - Rituximab versus cyclophosphamide for ANCA-associated vasculitis JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa0909905 DO - 10.1056/NEJMoa0909905 ID - Stone2010 ER - TY - JOUR AU - Specks, U. AU - Merkel, P. A. AU - Seo, P. PY - 2013 DA - 2013// TI - Efficacy of remission-induction regimens for ANCA-associated vasculitis JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1213277 DO - 10.1056/NEJMoa1213277 ID - Specks2013 ER - TY - JOUR AU - Jones, R. B. AU - Furuta, S. AU - Tervaert, J. W. PY - 2015 DA - 2015// TI - Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial JO - Ann Rheum Dis VL - 74 UR - https://doi.org/10.1136/annrheumdis-2014-206404 DO - 10.1136/annrheumdis-2014-206404 ID - Jones2015 ER - TY - JOUR AU - Guillevin, L. AU - Pagnoux, C. AU - Karras, A. PY - 2014 DA - 2014// TI - Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1404231 DO - 10.1056/NEJMoa1404231 ID - Guillevin2014 ER - TY - JOUR AU - Guillevin, L. AU - Pagnoux, C. AU - Seror, R. PY - 2011 DA - 2011// TI - The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis study group (FVSG) cohort JO - Medicine (Baltimore) VL - 90 UR - https://doi.org/10.1097/MD.0b013e318205a4c6 DO - 10.1097/MD.0b013e318205a4c6 ID - Guillevin2011 ER - TY - JOUR AU - Kronbichler, A. AU - Kerschbaum, J. AU - Gründlinger, G. AU - Leierer, J. AU - Mayer, G. AU - Rudnicki, M. PY - 2016 DA - 2016// TI - Evaluation and validation of biomarkers in granulomatosis with polyangiitis and microscopic polyangiitis JO - Nephrol Dial Transplant VL - 31 UR - https://doi.org/10.1093/ndt/gfv336 DO - 10.1093/ndt/gfv336 ID - Kronbichler2016 ER - TY - JOUR AU - Ingegnoli, F. AU - Castelli, R. AU - Gualtierotti, R. PY - 2013 DA - 2013// TI - Rheumatoid factors: clinical applications JO - Dis Markers VL - 35 UR - https://doi.org/10.1155/2013/726598 DO - 10.1155/2013/726598 ID - Ingegnoli2013 ER - TY - JOUR AU - Pagnoux, C. AU - Seror, R. AU - Bérezné, A. AU - Rouabhia, S. AU - Goulvestre, C. AU - Guillevin, L. PY - 2010 DA - 2010// TI - Remittent non-destructive polysynovitis in P-ANCA-positive vasculitis patients with anti-CCP antibodies JO - Joint Bone Spine VL - 77 UR - https://doi.org/10.1016/j.jbspin.2010.02.013 DO - 10.1016/j.jbspin.2010.02.013 ID - Pagnoux2010 ER - TY - JOUR AU - Mukhtyar, C. AU - Lee, R. AU - Brown, D. PY - 2009 DA - 2009// TI - Modification and validation of the Birmingham Vasculitis activity score (version 3) JO - Ann Rheum Dis VL - 68 UR - https://doi.org/10.1136/ard.2008.101279 DO - 10.1136/ard.2008.101279 ID - Mukhtyar2009 ER - TY - JOUR AU - Tervaert, J. W. AU - Damoiseaux, J. AU - Boomsma, M. M. AU - Stegeman, C. A. PY - 2002 DA - 2002// TI - Absence of anti-cyclic citrullinated peptide antibodies in antineutrophil cytoplasmic antibody-associated vasculitis JO - Arthritis Rheum VL - 46 UR - https://doi.org/10.1002/art.10087 DO - 10.1002/art.10087 ID - Tervaert2002 ER - TY - JOUR AU - Draibe, J. AU - Salama, A. D. PY - 2015 DA - 2015// TI - Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome JO - Springerplus VL - 4 UR - https://doi.org/10.1186/s40064-015-0835-8 DO - 10.1186/s40064-015-0835-8 ID - Draibe2015 ER - TY - JOUR AU - Newkirk, M. M. PY - 2002 DA - 2002// TI - Rheumatoid factors: host resistance or autoimmunity? JO - Clin Immunol VL - 104 UR - https://doi.org/10.1006/clim.2002.5210 DO - 10.1006/clim.2002.5210 ID - Newkirk2002 ER - TY - JOUR AU - Newkirk, M. M. AU - Fournier, M. J. AU - Shiroky, J. PY - 1995 DA - 1995// TI - Rheumatoid factor avidity in patients with rheumatoid arthritis: identification of pathogenic RFs which correlate with disease parameters and with the gal(0) glycoform of IgG JO - J Clin Immunol VL - 15 UR - https://doi.org/10.1007/BF01540882 DO - 10.1007/BF01540882 ID - Newkirk1995 ER - TY - JOUR AU - Dörner, T. AU - Egerer, K. AU - Feist, E. AU - Burmester, G. R. PY - 2004 DA - 2004// TI - Rheumatoid factor revisited JO - Curr Opin Rheumatol VL - 16 UR - https://doi.org/10.1097/00002281-200405000-00013 DO - 10.1097/00002281-200405000-00013 ID - Dörner2004 ER - TY - JOUR AU - van Schaardenburg, D. AU - Lagaay, A. M. AU - Breedveld, F. C. AU - Hijmans, W. AU - Vandenbroucke, J. P. PY - 1993 DA - 1993// TI - Rheumatoid arthritis in a population of persons aged 85 years and over JO - Br J Rheumatol VL - 32 UR - https://doi.org/10.1093/rheumatology/32.2.104 DO - 10.1093/rheumatology/32.2.104 ID - van Schaardenburg1993 ER - TY - JOUR AU - Ursum, J. AU - Bos, W. H. AU - van de Stadt, R. J. AU - Dijkmans, B. A. AU - van Schaardenburg, D. PY - 2009 DA - 2009// TI - Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems JO - Arthritis Res Ther VL - 11 UR - https://doi.org/10.1186/ar2704 DO - 10.1186/ar2704 ID - Ursum2009 ER - TY - JOUR AU - Mantovani, L. AU - Wilder, R. L. AU - Casali, P. PY - 1993 DA - 1993// TI - Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors JO - J Immunol VL - 151 ID - Mantovani1993 ER - TY - JOUR AU - Jennette, J. C. AU - Falk, R. J. PY - 2014 DA - 2014// TI - Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease JO - Nat Rev Rheumatol VL - 10 UR - https://doi.org/10.1038/nrrheum.2014.103 DO - 10.1038/nrrheum.2014.103 ID - Jennette2014 ER - TY - JOUR AU - Ralston, D. R. AU - Marsh, C. B. AU - Lowe, M. P. AU - Wewers, M. D. PY - 1997 DA - 1997// TI - Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors JO - J Clin Invest VL - 100 UR - https://doi.org/10.1172/JCI119662 DO - 10.1172/JCI119662 ID - Ralston1997 ER -